SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (2254)1/23/2001 5:04:41 PM
From: dalroiRead Replies (2) | Respond to of 4974
 
agreed

But why :

Shares outstanding: We anticipate that shares outstanding will increase at approximately the same rate (5-10%) as previous years, excluding equity issued in major alliances and acquisitions.

why do a share deal with share if one has 1.5b cash ?

either
1/ planning a very big (or multiple smaller) aquisitions
2/ they think shares overvalued (please no i put too much in mlnm)

is such a sentence a must in a report or does it forbode munching activities ?

cheers

Stefaan



To: scaram(o)uche who wrote (2254)1/23/2001 5:18:46 PM
From: nigel batesRead Replies (1) | Respond to of 4974
 
They can't quite live off the interest off of their interest...yet.

Cash: Guidance for the year is to remain cash neutral by the end of 2001 with a cash balance of approximately $1.5 billion.
* Shares outstanding: We anticipate that shares outstanding will increase at approximately the same rate (5-10%) as previous years, excluding equity issued in major alliances and acquisitions


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News